Browsing by Subject "Antineoplastic agents."
Now showing items 1-5 of 5
-
A current insight into Aurora kinase inhibitors and their potential as anticancer agents
(Brac University, 2024-03)The Aurora kinases, comprising Aurora A, Aurora B, and Aurora C, constitute a family of serine/threonine protein kinases that plays a fundamental role in ensuring precise mitotic progression, regulating multiple phases of ... -
Pooled efficacy analysis of phase II clinical trials of recurrent Glioblastoma
(Brac University, 2024-10)Recurrent glioblastoma require more research due to its wide spread prevalence among people. Researchers are working tirelessly to enhance the accessibility, ease the evaluation as well as ensure the validation of the end ... -
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
(Brac University, 2024-01)This review delves into the intricate landscape of Poly ADP-ribose polymerase (PARP) inhibitors, specifically focusing on two notable contenders in cancer therapy – Talazoparib and Olaparib. By targeting the DNA Damage ... -
A review on synthesis and SARs of select natural alkaloids as anticancer agents
(Brac University, 2024-10)Cancer is the leading cause of death worldwide. It is defined as the uncontrolled growth of abnormal cells in the body that affects healthy cells, have deleterious effects on vital organ functions and eventually death. New ... -
A review on the use of carfilzomib and bortezomib in the treatment of multiple myeloma
(Brac University, 2024-09)Many people worldwide suffer from multiple myeloma, a blood cancer that is fatal and difficult to treat. Therapy has advanced significantly, but recurrence and treatment resistance remain significant issues. Two important ...
